NEW YORK, May 6 (GenomeWeb News) - Shares in Ciphergen were down 6.06 percent, or $.10, at $1.55 in mid-afternoon trading after the company yesterday reported a 50-percent drop in revenues and widened losses for the first quarter of 2005.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.